BioSpace News Archive

PerfectServe®, a leading provider of cloud-based clinical communication and collaboration solutions, unveiled the next generation of its Nurse Mobility solution to further strengthen a growing platform that already counts 230,000 nurses among its user base.

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will be participating in the Cutting Edge of Transplantation (CEoT) conference taking place March 5-7, 2020 in Phoenix, Arizona .

Evolus, Inc. (NASDAQ: EOLS) today provided the following statement: “In several media reports this week, Medytox has made comments on the International Trade Commission (ITC) case, which Evolus believes are speculative and intended to create confusion in the U.S. market ahead of the ITC Judge’s initial determination in June 2020 and the ITC’s final determination, which is targeted for October 2020.

Devices Found to Present Unreasonable and Substantial Risk of Illness or Injury

Cigna Corporation (NYSE: CI) announced today that it has commenced tender offers to purchase for cash (1) up to $500,000,000 (the " 2022 Notes Aggregate Maximum Principal Amount ") of Cigna Holding Company’s 4.000% Senior Notes due 2022, Cigna Corporation’s 4.000% Senior Notes due 2022, Express Scripts Holding Company’s 3.900%

Solutions help optimize unit processes and deliver filtration consistency to protect downstream unit operations while reducing operating costs,

Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that it is expanding the dose range of Metablok (LSALT peptide) for future Phase II trials targeting inflammation in the lung, the kidney and/or the liver by adding a cohort of eight healthy volunteers to receive the highest daily dose tested to date for three consecutive days

PatientPoint®, the trusted leader in engagement solutions committed to making every doctor-patient engagement better®, today launched three new digital products further extending the reach of its suite of interactive patient engagement products.

Business Activity Index at 57.8%; New Orders Index at 63.1%; Employment Index at 55.6%

The management team will discuss the company’s novel siRNA therapy platform